Managing Mild Asthma

Introduction to Asthma Management

The American Academy of Allergy, Asthma, and Immunology recommends optimizing controller medication regimens and providing clear education on rescue medication use for children with mild asthma symptoms but normal vital signs 1
The American Thoracic Society suggests that parents may be misinterpreting normal variations in breathing or minor symptoms as requiring emergency intervention, highlighting the need for patient education 2

The National Asthma Education and Prevention Program indicates that a child with mild asthma symptoms but normal vital signs likely has well-controlled or intermittent asthma that doesn't require nebulizer treatment at that moment 1
The American Academy of Pediatrics recommends assessing the current controller regimen, as it may be inadequate, leading to more frequent mild symptoms that prompt clinic visits 1

The Global Initiative for Asthma recommends starting or intensifying inhaled corticosteroid (ICS) therapy if the child is using rescue medication more than twice per week, as this indicates the need for controller therapy rather than repeated rescue treatments 1
The American College of Allergy, Asthma, and Immunology suggests that low-dose ICS reduces severe exacerbations and improves symptom control even in patients with infrequent symptoms 1
The National Institutes of Health recommends providing a detailed written asthma action plan that clearly delineates when to use home rescue medication versus when to seek medical attention 1, 2

The American Thoracic Society indicates that signs requiring immediate treatment include inability to complete sentences in one breath, respiratory rate >25 breaths/min, heart rate >110 beats/min, peak expiratory flow (PEF) <50% of predicted or personal best, and visible respiratory distress, use of accessory muscles, or audible wheezing 4, 5

The American Academy of Allergy, Asthma, and Immunology recommends a written asthma action plan with specific instructions, including a green zone (well-controlled), yellow zone (caution), and red zone (medical alert) 1, 2
The National Asthma Education and Prevention Program suggests that the green zone includes no symptoms or minimal symptoms, continuing daily controller medication, and using SABA only as needed for exercise or occasional symptoms 1
The American College of Allergy, Asthma, and Immunology recommends that the yellow zone includes increased symptoms, cough, or mild wheezing, using SABA at home every 4 hours as needed, and contacting the clinic for assessment if symptoms persist beyond 24 hours or worsen 1, 5
The Global Initiative for Asthma indicates that the red zone includes any of the objective criteria listed above, no improvement after SABA treatment at home, and seeking immediate medical attention 4, 5

The American Academy of Pediatrics recommends scheduling regular monitoring visits rather than reactive visits for mild symptoms, with follow-up intervals every 2-6 weeks initially and every 1-6 months once control is achieved 1
The National Institutes of Health suggests assessing controller medication adherence, inhaler technique, and symptom patterns at each visit 1, 2

The American Thoracic Society recommends teaching parents to monitor peak flow at home if the child is old enough, which provides objective data to guide decision-making 1, 6
The American Academy of Allergy, Asthma, and Immunology suggests explaining to parents that nebulizer treatments are not inherently "better" than metered-dose inhalers (MDIs) with spacers for mild symptoms 6

The National Asthma Education and Prevention Program indicates that critical pitfalls to avoid include validating unnecessary clinic visits, allowing SABA overreliance without addressing underlying inflammation, underestimating the importance of patient education, and failing to assess and correct inhaler technique 1, 2